Sort   by:  
 Page size 
UnknownNew Therapeutics in HER2-Positive Advanced Breast Cancer: Towards a Change in Clinical Practices?pi.
Not available
S-EPMC7352740 | biostudies-literature
UnknownDurable disease control and refractory bullous pemphigoid after immune checkpoint inhibitor discontinuation in metastatic renal cell carcinoma: A case report.
Not available
S-EPMC9524245 | biostudies-literature
UnknownMOVIE: a phase I, open-label, multicenter study to evaluate the safety and tolerability of metronomic vinorelbine combined with durvalumab plus tremelimumab in patients with advanced solid tumors.
Not available
S-EPMC9808477 | biostudies-literature
UnknownSoluble BTN2A1 Is a Potential Prognosis Biomarker in Pre-Treated Advanced Renal Cell Carcinoma.
Not available
S-EPMC8096349 | biostudies-literature
UnknownMetastatic Renal Medullary and Collecting Duct Carcinoma in the Era of Antiangiogenic and Immune Checkpoint Inhibitors: A Multicentric Retrospective Study.
Not available
S-EPMC8996870 | biostudies-literature
UnknownVitiligo Adverse Event Observed in a Patient With Durable Complete Response After Nivolumab for Metastatic Renal Cell Carcinoma.
Not available
S-EPMC6795279 | biostudies-literature
UnknownCirculating tumor DNA predicts efficacy of a dual AKT/p70S6K inhibitor (LY2780301) plus paclitaxel in metastatic breast cancer: plasma analysis of the TAKTIC phase IB/II study.
Not available
S-EPMC9120890 | biostudies-literature
TranscriptomicsRNA-seq of human breast cancer cell line MCF-7 treated for 24h with rapamycin or DMSO
Investigation of differential pre-mRNA splicing in breast cancer cell line MCF-7 treated with rapamycin compared to vehicle DMSO that are overexpressing TRIB3
ORGANISM(S): Homo sapiens 
2020-07-31 | E-MTAB-8726 | biostudies-arrayexpress
UnknownOutcomes of patients with HER2-negative metastatic breast cancer after platinum- and non-platinum-based first-line chemotherapy among patients with and without pathogenic germline BRCA1/2 mutations.
Not available
S-EPMC9681869 | biostudies-literature
UnknownMolecular Profiles of Advanced Urological Cancers in the PERMED-01 Precision Medicine Clinical Trial.
Not available
S-EPMC9100924 | biostudies-literature
Sort   by:  
 Page size